{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:41:57Z","timestamp":1789990917378,"version":"4.0.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T00:00:00Z","timestamp":1429488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123546","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T18:37:13Z","timestamp":1429555033000},"page":"e0123546","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK"],"prefix":"10.1371","volume":"10","author":[{"given":"Vuslat","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piraye","family":"Oflazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikret","family":"Aysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Durmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Poulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel P.","family":"Yentur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Gulsen-Parman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Tuzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feza","family":"Deymeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"A Vincent","year":"2001","journal-title":"The Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"DB Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"J Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"A Vincent","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","first-page":"82","article-title":"Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3","volume":"67","author":"A Rodgaard","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation","volume":"298","author":"DB Drachman","year":"1978","journal-title":"N Engl J Med"},{"key":"ref7","first-page":"159","article-title":"Myasthenia gravis","volume":"88","author":"A Vincent","year":"2002","journal-title":"Adv Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48\u201349","author":"S Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"W Hoch","year":"2001","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"DB Sanders","year":"2003","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in &apos;seronegative&apos; myasthenia gravis","volume":"131","author":"MI Leite","year":"2008","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"O Higuchi","year":"2012","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"B Zhang","year":"2014","journal-title":"PLoS ONE"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"B Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"P Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"A Pevzner","year":"2012","journal-title":"J Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.44.4.728","article-title":"Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis","volume":"44","author":"J Link","year":"1994","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1196\/annals.1254.032","article-title":"T cells and cytokines in the pathogenesis of acquired myasthenia gravis","volume":"998","author":"M Milani","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","article-title":"Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis","volume":"128","author":"L Mu","year":"2009","journal-title":"Immunology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-5728(94)90044-2","article-title":"Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells","volume":"50","author":"Q Yi","year":"1994","journal-title":"J Neuroimmunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1468-1331.2000.00056.x","article-title":"Decreased mRNA expression of TNFa and IL-10 in non-stimulated peripheral blood mononuclear cells in myasthenia gravis","volume":"7","author":"W-X Huang","year":"2000","journal-title":"Eur J Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1054\/jocn.2001.1028","article-title":"Cytokine secretion by peripheral blood mononuclear cells in myasthenia gravis","volume":"9","author":"H Yoshikawa","year":"2002","journal-title":"J Clin Neurosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaut.2011.05.006","article-title":"Complement and cytokine based therapeutic strategies in myasthenia gravis","volume":"37","author":"E Tuzun","year":"2011","journal-title":"J Autoimmun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis","volume":"52","author":"JS Yi","year":"2014","journal-title":"J Autoimmun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2014.02.012","article-title":"Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice","volume":"151","author":"C Ulusoy","year":"2014","journal-title":"Clin Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1128\/IAI.65.3.1122-1125.1997","article-title":"Interleukin-12 suppresses immunoglobulin E production but enhances immunoglobulin G4 production by human peripheral blood mononuclear cells","volume":"65","author":"BA de Boer","year":"1997","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.160.7.3555","article-title":"IgE versus IgG4 production can be differentially regulated by IL-10","volume":"160","author":"P Jeannin","year":"1998","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"JC Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","article-title":"T helper type 17 cells expand in patients with myasthenia-associated thymoma","volume":"76","author":"Z Wang","year":"2012","journal-title":"Scand J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cei.12272","article-title":"Serum cytokine and chemokine profiles in patients with myasthenia gravis","volume":"176","author":"A Uzawa","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10072-013-1460-3","article-title":"Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis","volume":"35","author":"Y Li","year":"2013","journal-title":"Neurol Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cellimm.2005.01.001","article-title":"IL-21 effects on human IgE production in response to IL-4 or IL-13","volume":"231","author":"N Wood","year":"2004","journal-title":"Cell Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.33320","article-title":"Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease","volume":"64","author":"A Tanaka","year":"2012","journal-title":"Arthritis & Rheumatism"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"TL Stevens","year":"1988","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1468-1331.2009.02729.x","article-title":"Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis","volume":"16","author":"JH Yeh","year":"2009","journal-title":"Eur J Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2009.10.040","article-title":"Clinical implications of the type 1\/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients","volume":"627","author":"M Masuda","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"J Diaz-Manera","year":"2012","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.4049\/jimmunol.166.11.6893","article-title":"Blockade of CD40 Ligand Suppresses Chronic Experimental Myasthenia Gravis by Down-Regulation of Th1 Differentiation and Up-Regulation of CTLA-4","volume":"166","author":"SH Im","year":"2001","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<946::AID-MUS16>3.0.CO;2-4","article-title":"Altered expression of costimulatory molecules in myasthenia gravis","volume":"23","author":"N Teleshova","year":"2000","journal-title":"Muscle & Nerve"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2567.2005.02244.x","article-title":"Differential responses of human B-lymphocyte subpopulations to graded levels of CD40-CD154 interaction","volume":"116","author":"S Neron","year":"2005","journal-title":"Immunology"},{"key":"ref41","first-page":"1","article-title":"B cells produce less IL-10, IL-6 and TNF-alpha in myasthenia gravis","author":"V Yilmaz","year":"2014","journal-title":"Autoimmunity"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clim.2007.10.001","article-title":"Decrease of CD4(+)CD25(high)Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis","volume":"126","author":"X Li","year":"2008","journal-title":"Clin Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T16:43:33Z","timestamp":1691599413000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123546"}},"subtitle":[],"editor":[{"given":"Lin","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,20]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123546","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,20]]}}}